Bendamustine and Dexamethasone in Patients With Relapsed AL Amyloidosis
Status:
Completed
Trial end date:
2019-07-03
Target enrollment:
Participant gender:
Summary
The study is being done to see if the combination of bendamustine and dexamethasone will help
people with amyloidosis that has returned after standard treatment, and to to estimate the
partial hematologic response rate (PHR).